Miragen Miragen Therapeutics, Signal Genetics Complete Merger, New Financing Round Privately held Miragen will pick up Signal's Nasdaq listing, and the combined company is scheduled to begin trading today. Miragen Therapeutics, Signal Genetics Agree to Merge The combined company will be focused on Miragen's microRNA therapeutics programs, following the divestiture of Signal's molecular diagnostic assets. Miragen Aims to File Two INDs in '15, Go Public in '16 Premium Despite an initial focus on cardiovascular disease, Miragen has moved programs in hematological cancer and fibrosis to the front of its pipeline. Miragen, Servier Extend microRNA Drug Alliance Premium NEW YORK (GenomeWeb) – Miragen Therapeutics this week announced that its research and development collaboration with France's Servier has been extended by two years to October 2016. People in the News: Dinah Sah, Bernard Ravina, David Rodman, Casi DeYoung Premium Voyager Therapeutics, a startup developing adeno-associated viral vector therapies, including RNAi-based ones, for central nervous system disorders, has named Dinah Sah as its senior vice president of neuroscience. Nov 14, 2013 Monsanto, Miragen Data Further Contradicts Findings of Dietary microRNA Uptake Premium Jun 13, 2013 People in the News: Aimee Jackson, Christopher Morl, Stelios Papadopoulos, Olivier Voinnet Premium May 23, 2013 MiRagen Hits First Milestone in Servier microRNA Drug Partnership Premium Mar 7, 2013 Miragen Licenses miR-145 IP from University of Glasgow Premium Jan 10, 2013 Santaris, Miragen Expand microRNA Partnership to Include Additional Targets Premium Dec 20, 2012 In 2012, Top microRNA Drug Developers Pull in Nearly $150M in Funding Premium Oct 25, 2012 Mirna Closes $34.5M Series C Round as microRNA Drugs Gain Investor Interest Premium Apr 26, 2012 Miragen Closes $20M Series B Financing Premium Jan 12, 2012 Silence Inks Tech-Evaluation Deal with Miragen Premium Jan 5, 2012 In 2011, miRNAs Move Beyond 'Scientific Curiosity' as Big Pharma Externalizes Oligo Drug Development Premium Nov 10, 2011 Miragen Publishes New Data on Role of miR-15 in Cardiovascular Disease Premium Oct 20, 2011 Miragen Seals microRNA Drug Partnership with Servier Worth Up to $1B Premium Sep 15, 2011 NIH Awards $1.2M in Three SBIR Grants to Fund Projects Studying miRNA Inhibition, Detection Premium Sep 8, 2011 Miragen, UT Southwestern Show miR-208 Inhibition Improves Survival in Rodent Heart-Failure Models Premium Aug 25, 2011 RxGen, Miragen Awarded NIH Grant for microRNA Research Premium Jul 28, 2011 Miragen, UT Southwestern Team Publishes Data Linking miR-15 to Cardiomyogenesis Premium Jul 7, 2011 UT Southwestern Team Reports on Link Between miR-133a and Rare Muscle Condition Premium Jun 23, 2011 Miragen Issued Notice of Allowance for microRNA-Related IP Premium May 26, 2011 Miragen Adds Myeloproliferative Disease Drug to Pipeline, Sees IND in 2012 Premium Jan 27, 2011 RXi Technology Shows Potential as miRNA Mimic In Vitro Premium Load More Breaking News Ancient Sequencing Study Expands View of Historical Population Interactions in Southern China Overexpressed Cancer Testis Antigen Could Reflect Therapeutic Target in Liver Cancer My Gene Counsel, Foundation for Prader-Willi Research Partner on Genetic Testing Study MicroGenDx Acquires Sequencing Lab RTL Genomics Pacific Biosciences, Rady Children's Collaborate on Study of WGS-Based Rare Disease Dx Codex DNA Closes $122.7M IPO The Scan Gone, But Now Reconstructed SARS-CoV-2 Genomes In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database. Rare Heart Inflammation Warning The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports. Sandwich Sampling The New York Times sent tuna sandwiches for PCR analysis. Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.